Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: Role of fibroblast growth factor 8 (FGF8) in animal models of osteoarthritis

Figure 3

FGF8 enhanced the release of promatrix metalloproteinase-3 and prostaglandin E2 from rabbit articular chondrocyte cultures. Chondrocytes were treated without (none) or with 100 ng/ml FGF8 and various concentrations of anti-FGF8 antibody (Ab) (1, 3 and 10 μg/ml) for 48 hours. Concentrations of (a) promatrix metalloproteinase-3 (proMMP-3) and (b) prostaglandin E2 (PGE2) in the culture medium were determined by ELISA. Each column represents the mean ± standard error. Representative data of two or three independent experiments. ##P < 0.01 compared with the no treatment group (Aspin–Welch test), ***P < 0.001 compared with FGF8 alone (Dunnett test).

Back to article page